PCMA Asks DOJ and FTC to Investigate Role of Large Drug Wholesalers in Generic Drug Prices, Acquisition Costs for Pharmacies

(WASHINGTON, D.C.) – Yesterday, the Pharmaceutical Care Management Association (PCMA) submitted comments to the Department of Justice (DOJ) Antitrust Division and the Federal Trade Commission (FTC) encouraging them to seek information about the business practices of large drug wholesaler companies. Earlier this year, DOJ and FTC issued a request for public comments about reinstating guidelines […]